JOHN PETER MCLAUGHLIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN PETER MCLAUGHLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN PETER MCLAUGHLIN. JOHN PETER MCLAUGHLIN is CEO in PDL BIOPHARMA, INC. ($PDLI) and Director in PDL BIOPHARMA, INC. ($PDLI) and President, CEO in PDL BIOPHARMA, INC. ($PDLI) and Director in ROCKWELL MEDICAL, INC. ($RMTI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Chief Executive Officer in ANESIVA, INC. ($CGTK) and President & CEO in ANESIVA, INC. ($CGTK) and Director in LENSAR, Inc. ($LNSR) and Director in Adverum Biotechnologies, Inc. ($AAVL).
Latest Insider Trading Transactions of JOHN PETER MCLAUGHLIN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, CGTK, LNSR, PDLI, RMTI, SGEN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2021 | LNSR | LENSAR, Inc. | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 8.62 | 13,445 | 115,896 | 13,445 | |
| Feb 02 2021 | LNSR | LENSAR, Inc. | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 7.08 | 28,249 | 200,003 | 28,249 | |
| Dec 22 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Sell | S | 2.61 | 277,934 | 724,574 | 200,000 | 477.9 K to 200 K (-58.15 %) |
| Dec 22 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Sell | S | 2.62 | 50,000 | 131,200 | 477,934 | 527.9 K to 477.9 K (-9.47 %) |
| Aug 24 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 3.63 | 118,671 | 430,776 | 118,671 | |
| Aug 24 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 25,826 | 0 | 527,934 | 502.1 K to 527.9 K (+5.14 %) |
| May 20 2020 | RMTI | ROCKWELL MEDICAL, ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 2.04 | 34,024 | 69,409 | 34,024 | |
| May 20 2020 | RMTI | ROCKWELL MEDICAL, ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 51,800 | 0 | 86,974 | 35.2 K to 87 K (+147.27 %) |
| Sep 06 2019 | RMTI | ROCKWELL MEDICAL, ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 2.56 | 28,372 | 72,632 | 28,372 | |
| Sep 06 2019 | RMTI | ROCKWELL MEDICAL, ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 22,559 | 0 | 22,559 | 0 to 22.6 K |
| Jul 08 2019 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
| Jan 09 2019 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | CEO | Sell | D | 0.00 | 123,449 | 0 | 502,108 | 625.6 K to 502.1 K (-19.73 %) |
| Dec 28 2018 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | CEO | Sell | D | 0.00 | 627,228 | 0 | 625,557 | 1.3 M to 625.6 K (-50.07 %) |
| Jun 12 2018 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | CEO | Option Exercise | A | 2.94 | 1,922,100 | 5,650,974 | 1,922,100 | |
| Dec 19 2017 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | CEO | Sell | D | 0.00 | 151,678 | 0 | 1,252,785 | 1.4 M to 1.3 M (-10.80 %) |
| Mar 07 2017 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | President, CEO | Grant | A | 2.04 | 588,235 | 1,199,999 | 1,404,463 | 816.2 K to 1.4 M (+72.07 %) |
| Dec 15 2016 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | President, CEO | Sell | D | 0.00 | 5,168 | 0 | 816,228 | 821.4 K to 816.2 K (-0.63 %) |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 38.82 | 9,260 | 359,473 | 9,260 | |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 3,700 | 0 | 39,400 | 35.7 K to 39.4 K (+10.36 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 4.80 | 11,905 | 57,144 | 11,905 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 8,333 | 0 | 10,333 | 2 K to 10.3 K (+416.65 %) |
| Jan 28 2016 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | President, CEO | Grant | A | 3.22 | 403,727 | 1,300,001 | 821,396 | 417.7 K to 821.4 K (+96.66 %) |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 39.94 | 9,260 | 369,844 | 9,260 | |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 3,700 | 0 | 35,700 | 32 K to 35.7 K (+11.56 %) |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 39.35 | 7,000 | 275,450 | 7,000 | |
| Apr 23 2015 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| May 12 2006 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | Chief Executive Off ... | Option Exercise | A | 7.46 | 250,000 | 1,865,000 | 250,000 | |
| Nov 14 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | Chief Executive Off ... | Option Exercise | A | 2.45 | 100,000 | 245,000 | 100,000 | |
| Nov 14 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | Chief Executive Off ... | Option Exercise | D | 8.28 | 100,000 | 828,000 | 0 | |
| May 02 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Option Exercise | A | 2.25 | 100,000 | 225,000 | 100,000 | |
| Mar 28 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Gift | G | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Mar 28 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Gift | G | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Mar 28 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Gift | G | 0.00 | 25,000 | 0 | 249,603 | 274.6 K to 249.6 K (-9.10 %) |
| Mar 28 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Gift | G | 0.00 | 25,000 | 0 | 274,603 | 299.6 K to 274.6 K (-8.34 %) |
| Jan 05 2005 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Option Exercise | A | 8.28 | 100,000 | 828,000 | 100,000 | |
| Nov 22 2004 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Grant | A | 0.00 | 2,000 | 0 | 299,603 | 297.6 K to 299.6 K (+0.67 %) |
| Nov 16 2004 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Buy | J | 0.00 | 103 | 0 | 297,603 | 297.5 K to 297.6 K (+0.03 %) |
| Aug 11 2004 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Option Exercise | M | 1.20 | 10,000 | 12,000 | 265,000 | |
| Aug 11 2004 | CGTK | ANESIVA, INC. | MCLAUGHLIN JOHN PETER | President & CEO | Buy | M | 1.20 | 10,000 | 12,000 | 297,500 | 287.5 K to 297.5 K (+3.48 %) |
Page: 1